Followers | 53 |
Posts | 3489 |
Boards Moderated | 0 |
Alias Born | 02/05/2014 |
Tuesday, October 21, 2014 2:28:43 PM
DNA very much has real products. I have personally purchased and enjoyed consuming several of them. Their products are not the problem; their lack of advertising is the problem.
DNA had their product in every Quik Trip store (about 115 stores) in the Dallas/Fort Worth Metroplex, which is the fourth largest metropolitan area in the country. I very thoroughly documented this back in August:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105043539
With eight million thirsty, exhausted people in the D/FW Metroplex, DNA had complete market penetration in a market large enough to completely sustain and grow the company without even needing sales from any other market in the country, and they blew the opportunity!
Due to lack of sales from NO local advertising, there was insufficient consumer awareness of the products leading to poor sales, and DNA's products were pulled out of all stores in the Dallas/Fort Worth area.
Even the people who worked in the stores were largely unaware the DNA products were in their stores only 15 feet away from the checkout counter. I know because I asked people at over a dozen stores when DNA was still in the stores, and in over 3/4 of the stores, the store workers were completely unaware that DNA existed or that the products were offered for sale in their stores. This was after DNA products had been in their stores for over six months! If store employees don't even know about the products, how can one expect consumers to know about that in order to purchase them?
Continued strategy of placing product in new areas with ZERO local advertising is a guarantee for continued failure. It is that simple...
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM